Search Results

There are 2913 results for: content related to: The Efficacy and Safety of Valsartan in Obese and Non-Obese Pediatric Hypertensive Patients

  1. You have free access to this content
    Clinical Experience With Angiotensin Receptor Blockers With Particular Reference to Valsartan

    The Journal of Clinical Hypertension

    Volume 6, Issue 8, August 2004, Pages: 445–451, Steven G. Chrysant and 1 George S. Chrysant 2

    Version of Record online : 25 MAY 2007, DOI: 10.1111/j.1524-6175.2004.03449.x

  2. You have full text access to this OnlineOpen article
    Valsartan vs. other angiotensin II receptor blockers in the treatment of hypertension: a meta-analytical approach

    International Journal of Clinical Practice

    Volume 63, Issue 5, May 2009, Pages: 766–775, R. M. Nixon, E. Müller, A. Lowy and H. Falvey

    Version of Record online : 3 APR 2009, DOI: 10.1111/j.1742-1241.2009.02028.x

  3. Angiotensin II-receptor blocker dosages: How high should we go?

    International Journal of Clinical Practice

    Volume 60, Issue 2, February 2006, Pages: 179–183, R. Düsing

    Version of Record online : 1 FEB 2006, DOI: 10.1111/j.1742-1241.2006.00779.x

  4. The benefits of valsartan in the treatment of heart failure: results from Val-HeFT

    International Journal of Clinical Practice

    Volume 58, Issue 2, February 2004, Pages: 184–191, L-B Tan, 1 D. Schlosshan and 1 S. G. Williams 2

    Version of Record online : 8 MAR 2004, DOI: 10.1111/j.1368-5031.2004.0134.x

  5. You have free access to this content
    Office and Ambulatory Blood Pressure–Lowering Effects of Combination Valsartan/Hydrochlorothiazide vs Hydrochlorothiazide-Based Therapy in Obese, Hypertensive Patients

    The Journal of Clinical Hypertension

    Volume 13, Issue 10, October 2011, Pages: 731–738, Leopoldo Raij, Brent M. Egan, Dion H. Zappe, Das Purkayastha, Rita Samuel and James R. Sowers

    Version of Record online : 14 JUL 2011, DOI: 10.1111/j.1751-7176.2011.00499.x

  6. Angiotensin receptor blockers for heart failure

    Intervention Review

    The Cochrane Library

    Balraj S Heran, Vijaya M Musini, Ken Bassett, Rod S Taylor and James M Wright

    Published Online : 18 APR 2012, DOI: 10.1002/14651858.CD003040.pub2

  7. You have full text access to this OnlineOpen article
    Targeting effective blood pressure control with angiotensin receptor blockers

    International Journal of Clinical Practice

    Volume 60, Issue 3, March 2006, Pages: 315–320, R. Asmar

    Version of Record online : 22 FEB 2006, DOI: 10.1111/j.1368-5031.2006.00784.x

  8. You have free access to this content
    Evaluation of the Dose Response With Valsartan and Valsartan/Hydrochlorothiazide in Patients With Essential Hypertension

    The Journal of Clinical Hypertension

    Volume 9, Issue 2, February 2007, Pages: 103–112, Matthew R. Weir, 1 Nora Crikelair, 2 Drew Levy, 2 Ricardo Rocha, 2 Venkatram Kuturu and 2 Robert Glazer 2

    Version of Record online : 2 FEB 2007, DOI: 10.1111/j.1524-6175.2007.06415.x

  9. You have free access to this content
    Efficacy of the Combination of Amlodipine and Valsartan in Patients With Hypertension Uncontrolled With Previous Monotherapy: The Exforge in Failure After Single Therapy (EX-FAST) Study

    The Journal of Clinical Hypertension

    Volume 10, Issue 3, March 2008, Pages: 185–194, Yves Allemann, Belen Fraile, Michel Lambert, Michaela Barbier, Philippe Ferber and Joseph L. Izzo Jr

    Version of Record online : 10 APR 2008, DOI: 10.1111/j.1751-7176.2008.07516.x

  10. You have free access to this content
    Comparative Efficacy of Aliskiren/Valsartan vs Valsartan in Nocturnal Dipper and Nondipper Hypertensive Patients: A Pooled Analysis

    The Journal of Clinical Hypertension

    Volume 14, Issue 5, May 2012, Pages: 299–306, Thomas D. Giles, 1 Thomas Alessi, 2 Das Purkayastha and 2 Dion Zappe 2

    Version of Record online : 16 MAR 2012, DOI: 10.1111/j.1751-7176.2012.00608.x

  11. You have free access to this content
    Treating Systolic Hypertension in the Very Elderly With Valsartan-Hydrochlorothiazide vs Either Monotherapy: ValVET Primary Results

    The Journal of Clinical Hypertension

    Volume 13, Issue 10, October 2011, Pages: 722–730, Joseph L. Izzo Jr, Howard S. Weintraub, Daniel A. Duprez, Das Purkayastha, Dion Zappe, Rita Samuel and William C. Cushman

    Version of Record online : 14 JUL 2011, DOI: 10.1111/j.1751-7176.2011.00498.x

  12. You have full text access to this OnlineOpen article
    Maximising antihypertensive effects of angiotensin II receptor blockers with thiazide diuretic combination therapy: focus on irbesartan/hydrochlorothiazide

    International Journal of Clinical Practice

    Volume 61, Issue 12, December 2007, Pages: 2093–2102, J. M. Flack

    Version of Record online : 20 SEP 2007, DOI: 10.1111/j.1742-1241.2007.01577.x

  13. Development and validation of a reliable and rapid LC-MS/MS method for simultaneous quantification of sacubitril and valsartan in rat plasma and its application to a pharmacokinetic study

    Biomedical Chromatography

    Volume 30, Issue 9, September 2016, Pages: 1467–1475, Raja Haranadha Babu Chunduri and Gowri Sankar Dannana

    Version of Record online : 1 MAR 2016, DOI: 10.1002/bmc.3707

  14. You have full text access to this OnlineOpen article
    Novel mechanism of cardiac protection by valsartan: synergetic roles of TGF-β1 and HIF-1α in Ang II-mediated fibrosis after myocardial infarction

    Journal of Cellular and Molecular Medicine

    Volume 19, Issue 8, August 2015, Pages: 1773–1782, Xizhong Sui, Hongchao Wei and Dacheng Wang

    Version of Record online : 30 MAR 2015, DOI: 10.1111/jcmm.12551

  15. Pharmacokinetics of Valsartan in Pediatric and Adolescent Subjects With Hypertension

    The Journal of Clinical Pharmacology

    Volume 49, Issue 2, February 2009, Pages: 235–241, Dr Jeffrey Blumer, Dr Donald L. Batisky, Dr Thomas Wells, Dr Victor Shi, Ms Susan Solar-Yohay and Dr Gangadhar Sunkara

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270008329547

  16. You have free access to this content
    Angiotensin Receptor Blockers: Pharmacology, Efficacy, and Safety

    The Journal of Clinical Hypertension

    Volume 13, Issue 9, September 2011, Pages: 677–686, Addison A. Taylor, Helmy Siragy and Shawna Nesbitt

    Version of Record online : 27 JUL 2011, DOI: 10.1111/j.1751-7176.2011.00518.x

  17. Bioavailability of valsartan oral dosage forms

    Clinical Pharmacology in Drug Development

    Volume 3, Issue 2, March/April 2014, Pages: 132–138, Gangadhar Sunkara, Girish Bende, Anisha E. Mendonza, Susan Solar-Yohay, Shibadas Biswal, Srikanth Neelakantham, Robert Wagner, Jimmy Flarakos, Yiming Zhang and Venkateswar Jarugula

    Version of Record online : 10 OCT 2013, DOI: 10.1002/cpdd.56

  18. Kicking the tyres of a heart failure trial: physician response to the approval of sacubitril/valsartan in the USA

    European Journal of Heart Failure

    Volume 18, Issue 10, October 2016, Pages: 1211–1219, Milton Packer

    Version of Record online : 10 AUG 2016, DOI: 10.1002/ejhf.623

  19. You have free access to this content
    Effects of Valsartan or Amlodipine Alone or in Combination on Plasma Catecholamine Levels at Rest and During Standing in Hypertensive Patients

    The Journal of Clinical Hypertension

    Volume 9, Issue 3, March 2007, Pages: 168–178, Jacques de Champlain, 1 Maria Karas, 1 Linda Assouline, 3 Reginald Nadeau, 2 A. Robert LeBlanc, 2 Bruno Dubé and 2 Pierre Larochelle 1

    Version of Record online : 20 MAR 2007, DOI: 10.1111/j.1524-6175.2007.05938.x

  20. You have free access to this content
    Initial Combination Therapy Compared With Monotherapy in Diabetic Hypertensive Patients

    The Journal of Clinical Hypertension

    Volume 10, Issue 9, September 2008, Pages: 668–676, James R. Sowers, Guido Lastra, Ricardo Rocha, Yodit Seifu, Nora Crikelair and Drew G. Levy

    Version of Record online : 24 SEP 2008, DOI: 10.1111/j.1751-7176.2008.00003.x